What is the purpose and procedure of a wet wrap followed by a dry wrap in topical dermatologic therapy?

Wet Wrap Then Dry Wrap: Definition and Procedure

Wet wrap therapy consists of applying topical medication (typically corticosteroids) to affected skin, then covering it with a warm, moist inner layer of cotton cloth or tubular bandages, followed by a dry outer layer of cotton cloth or bandages on top 1.

Purpose and Mechanism

The wet-then-dry wrap technique serves multiple therapeutic functions:

• Enhances medication penetration: Wet dressings promote trans-epidermal penetration of topical corticosteroids, increasing their effectiveness 1
• Physical barrier: Acts as an effective barrier against persistent scratching, promoting healing of excoriated lesions 1
• Hydration: Maintains moisture at the skin surface, supporting the wound healing environment 2

Clinical Application

Wet wrap therapy with topical corticosteroids is recommended as an effective and relatively safe short-term second-line treatment for moderate to very severe atopic dermatitis 1.

Treatment Duration

• Standard duration: 3-7 days 1
• Maximum extension: Up to 14 days in severe cases 1
• Positioning in treatment algorithm: Should be considered ahead of systemic immunosuppressive therapies for patients failing conventional topical therapy 1

Procedure Specifics

1. Apply topical corticosteroid to all affected skin surfaces
2. Cover with warm, moist cotton cloth or tubular bandages (inner layer)
3. Apply dry cotton cloth or bandages over the wet layer (outer layer)
4. Leave in place as directed (often overnight)

Important Caveats and Safety Considerations

The Joint Task Force guidelines specifically discourage the use of topical calcineurin inhibitors (TCIs) in conjunction with wet wrap therapy 3. Use wet wraps only with topical corticosteroids, not with TCIs.

Potential Adverse Effects

Monitor for these complications, particularly with prolonged use:

• Infections: Higher frequency of secondary infections compared to emollients alone 2
• Folliculitis 3
• Skin maceration 3
• Hypothalamic-pituitary-adrenal axis suppression: Temporary suppression can occur due to enhanced systemic absorption of corticosteroids under occlusion 2

Risk Mitigation

• Limit treatment duration to recommended timeframes (3-7 days, maximum 14 days)
• Use appropriate potency corticosteroids for the body area being treated
• Monitor closely for signs of infection
• Avoid overuse to prevent complications 3

The dual-layer system (wet inner, dry outer) is essential to the technique—the moist layer enhances drug delivery while the dry outer layer maintains the occlusive environment and prevents external moisture loss.